• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>UnionBanCal Corporation

UnionBanCal Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. United Neuroscience Reports Positive Phase 1 Results for Active Vaccine UB -311 in Alzheimer’s Disease

    United Neuroscience Reports Positive Phase 1 Results for Active Vaccine UB -311 in Alzheimer’s Disease

  2. Hong Kong: A Gateway to Chinese Companies

    Although UnionBanCal's UB third-quarter earnings fell 5% compared to the same quarter last year to $1.20 per share, we are maintaining our $63 fair value estimate. We were troubled, but not entirely surprised, by the movement of deposits to interest-bearing accounts from non-interest-bearing ...

  3. Fund Times: Vanguard Opens the Spigots for Three Funds

    Plus, news on new Janus CIOs, fund-related political action, and more.

©2017 Morningstar Advisor. All right reserved.